Structure-based generative models (SBGMs) hold great promises for accelerating drug discovery by enabling target-aware molecular design. However, existing approaches face fundamental challenges: three-dimensional graph-based models can explicitly incorporate protein structural information but often generate chemically implausible molecules due to limited training data, while chemical language models (CLMs) produce chemically plausible molecules but struggle to effectively leverage three-dimensional structural information for structure-conditioned generation and hard to incorporate lead optimization functionality due to the nature of SMILES string. Here, we present StructureSAFE, a structure-aware chemical language model that resolves this trade-off by integrating protein structural and evolutionary encoders with the SAFE molecular representation via pretraining and finetuning training scheme, enabling both de novo hit identification and a comprehensive suite of lead optimization subtasks within a unified framework. Comprehensive benchmarking on the MolGenBench dataset demonstrates that StructureSAFE achieves state-of-the-art (SOTA) performance across multiple metrics, with particularly pronounced improvements in chemical plausibility relative to graph-based models lacking pretraining. Evaluation on a rigorously constructed held-out test set further confirms its ability to generate drug-like, synthetically accessible molecules with competitive predicted binding affinities for previously unseen targets on both hit identification and lead optimization setting. In silico case studies across four therapeutically relevant targets validate its capacity to generate chemically plausible molecules that recapitulate key binding interactions of known high-affinity ligands while proposing novel interactions for potential better affinity and exploring previously unknown regions of chemical space. Taking together, StructureSAFE represents a versatile and practical tool to provide high-quality candidate molecules for augmenting medicinal chemistry workflows in both hit identification and lead optimization campaigns.
A clear pattern is revealed in LLM spatial capabilities: while they still lag behind state-of-the-art approaches, they are promising and can handle multiple spatial constraints simultaneously, enabling scaling to heterogeneous setups.
Thomas MacDougall, Maksim Kuznetsov, Roman Schutski et al.· arXiv.org· 1 citation
Accurate prediction of drug-target binding affinity (DTA) is a key task in virtual screening. However, current computational methods face a key challenge: sequence-based approaches often fail to capture critical spatial information, while structure-based models rely on computationally expensive 3D coordinates, which re...
Junlin Xu, Ye Yuan, Menglong Hu et al.· IEEE journal of biomedical a...· 0 citations
ScrambleBench provides a holistic medicinal chemistry-oriented framework that identifies methodological strengths, limitations, and opportunities for future model development and highlights the importance of evaluating chemical diversity explicitly and using the recently proposed metrics such as Hamiltonian Diversity (...
Veincent Yap, Pan Xu, Frankie S. Mak et al.· Journal of Cheminformatics· 0 citations
Structure-based drug design (SBDD) models are central to modern pharmaceutical research, enabling the rational exploration of protein-ligand interactions at atomic resolution. However, most existing approaches frame molecular generation as an isolated optimization or a one-to-one matching task, overlooking the shared b...
Dong Xu, Zhang-Fan Yang, Junchuang Cai et al.· IEEE transactions on computa...· 1 citation
FragBERTa is introduced, a molecular fragment-aware transformer-based representation language model pretrained using masked language modeling on Sequential Attachment-based Fragment Embedding (SAFE) representations, suggesting that fragment-based string representations offer advantages over atom-level representations f...
Vilya-1 is introduced, a deep learning model that addresses two central challenges in macrocycle design: sampling biologically relevant conformations across arbitrary chemistries and predicting key developability properties such as membrane permeability.
Vilya Research Pascal Sturmfels, M. Salem, Naozumi Hiranuma et al.· arXiv.org· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.